Central retinal vein occlusion
Joel Salzmann (Geneva)
This presentation will briefly discuss the pathophysiology of CRVO
and summarize the design and recommendations of the CVOS study,
which is the only study with evidence strong enough to guide treatment
at the present time.
Innovative treatments for CRVO will be reviewed in detail, and their
effectiveness will be
discussed in the light of published data.